LGI1 and encephalitis: Previous studies on anti-LGI1 encephalitis using 18F-FDG PET have mainly focused on the metabolic alterations occurring within entire cerebral lobes (temporal, parietal, or frontal lobe), deep nuclei, or the hippocampus (12–15).